Monday, October 1, 2012

Health News: [cancer]

Yahoo! Alerts Yahoo! Health - My Alerts - Edit Alert
Monday, October 01, 2012 6:12 AM PDT

UPDATE 3-Cancer trials show 1 year on Roche's Herceptin is best
Reuters via Yahoo! Maktoob News Mon, 01 Oct 2012 05:10 AM PDT
* Roche trial favours status quo, French trial inconclusive * Experts say key message is one year of Herceptin is best * Results limit downside risk for Roche's Herceptin revenues LONDON, Oct 1 (Reuters) - The results of two studies intoRoche's breast cancer drug Herceptin published onMonday showed that the current standard treatment of taking thedrug for a year provides the best outcome for ...

Breast cancer patients live longer on Roche's TDM-1
Reuters via Yahoo! Maktoob News Mon, 01 Oct 2012 05:09 AM PDT
LONDON, Oct 1 (Reuters) - Women with an aggressive type ofadvanced breast cancer who were treated with an experimental"armed antibody" drug from Roche lived more than fivemonths longer than those receiving the standard drug cocktail,researchers said on Monday. Data from a Phase III trial of the drug, called trastuzumabemtansine or TDM-1, in HER2-positive breast cancer, showedpatients treated ...

Myths and misunderstandings obstructing efforts to prevent cancer
ANI via Yahoo! India News Mon, 01 Oct 2012 03:19 AM PDT
Washington, October 1 (ANI): Many people are highly misinformed about the important role lifestyle factors play in raising their risk of developing cancer, according to a new research.




See more health stories that match my keyword
Visit Yahoo! Health


You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment